Herrera, Fabian. “LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT”. Mediterranean Journal of Hematology and Infectious Diseases 16, no. 1 (April 30, 2024): e2024039. Accessed July 3, 2024. https://www.mjhid.org/mjhid/article/view/5613.